设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:中国医师协会
总编辑:
杨秋

编辑部主任:吴翔宇

邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

过刊目录

2021 年第 5 期 第 16 卷

新型冠状病毒肺炎合并2型糖尿病患者的临床特征及预后分析

Clinical characteristics and prognosis of patients with corona virus disease-19 and type 2 diabetes mellitus

作者:施金枝戴锴张倩杨凡陈晓蓓

英文作者:Shi Jinzhi Dai Kai Zhang Qian Yang Fan Chen Xiaobei

单位:武汉大学人民医院感染科430060

英文单位:Department of Infectious Diseases Renmin Hospital of Wuhan University Wuhan 430060 China

关键词:新型冠状病毒肺炎;2型糖尿病;临床特征

英文关键词:Coronavirusdisease-19;Type2diabetesmellitus;Clinicalcharacteristics

  • 摘要:
  • 目的 探讨新型冠状病毒肺炎(COVID-19)合并2型糖尿病患者的临床特征及预后。方法 收集武汉大学人民医院东院区202021日至2020310日收治的76COVID-19合并2型糖尿病患者的临床资料。总结患者的临床特征及预后。结果 76例患者中,男、女各占50.0%,平均年龄为(68±10)岁,普通型15例(19.7%)、重型37例(48.7%)、危重型24例(31.6%)。临床表现主要为发热(64例,84.2%)、干咳(50例,65.8%)和乏力(51例,67.1%)等。与普通型和重型患者比较,危重型患者的白细胞计数、中性粒细胞计数、天冬氨酸转氨酶、血尿素氮、血糖、乳酸脱氢酶、C反应蛋白>10 mg/L者比例、D-二聚体、N末端B型脑钠肽前体、肌酸激酶同工酶、肌红蛋白、高敏心肌肌钙蛋白Ihs-cTnI>0.04 μg/L者比例均高,而淋巴细胞计数、血小板计数、白蛋白水平、CD3CD4CD8细胞计数均低(均P<0.05)76 例患者中,出现呼吸衰竭26(34.2%)、急性心肌损伤9(11.8%)、休克6(7.9%)、肾衰竭3(3.9%);好转出院55(72.4%)、死亡21(27.6%),死亡者均为危重型患者,3组患者的病死率差异有统计学意义(P<0.05)结论 COVID-19合并2型糖尿病患者的病死率相对较高,其中危重型患者更容易出现多器官功能损害,预后更差。

  • Objective To investigate the clinical characteristics and prognosis of patients with corona virus disease-19(COVID-19) and type 2 diabetes mellitus. Methods The clinical data of 76 diabetic cases with COVID-19 in East District of Renmin Hospital of Wuhan University from February 1 to March 10, 2020 were collected. The clinical characteristics and prognosis were summarized. Results Among 76 cases, male and  females accounted for 50.0% and 50.0%, respectively, with an average age of (68±10) years. There were 15 cases of ordinary type(19.7%), 37 cases of severe type(48.7%) and 24 cases of critical type(31.6%). The main clinical manifestations were fever(64 cases, 84.2%), dry cough(50 cases, 65.8%), weakness(51 cases, 67.1%) and so on. Compared with the patients in ordinary type and severe type, white blood cell count, neutrophil count, aspartate transaminase, blood urea nitrogen, blood glucose, lactate dehydrogenase, ratio of C-reactive protein>10 mg/L, D-dimer, N terminal pro-brain natriuretic peptide, creatine kinase isoenzymes, myoglobin, ratio of high-sensitivity cardiac troponin I(hs-cTnI) >0.04 μg/L in critical type were higher; while the lymphocyte count, platelet count, albumin level, and the counts of CD3, CD4 and CD8 cells in critical type were lower (all P<0.05). Among the 76 cases, 26 cases(34.2%) had respiratory failure, 9 cases(11.8%) had acute myocardial injury, 6 cases(7.9%) had shock and 3 cases(3.9%) had renal failure. There were 55 cases (72.4%) discharged after improvement, and 21 cases (27.6%) died, all of the death cases were in the critical type. There was a significant difference in mortality among the patients of three types(P<0.05). Conclusions The mortality of type 2 diabetes mellitus patients with COVID-19 is relatively high. Critical patients are more likely to have multiple organ dysfunction and poor prognosis.

copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3

当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭